$OMIC News
Last published 1y ago
- 1y agoOMICSingular Highlights Key G4X™ Launch Milestones and Showcases Groundbreaking 3D Spatial Multiomic Performance at AGBTGlobeNewswireSAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., an innovator in high-throughput spatial multiomics technologies designed to advance precision medicine, today announced key development
- 1y agoOMICSingular Genomics Announces Closing of Acquisition by Deerfield ManagementGlobeNewswireSAN DIEGO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 1y agoEDBLENFNJWNOMICKuehn Law Encourages ENFN, EDBL, OMIC, and JWN Investors to Contact Law FirmGlobeNewswireNEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 1y agoLBRDAMRNSOMICVCSAKuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law FirmGlobeNewswireNEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures
- 1y agoOMICSingular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per ShareGlobeNewswireSAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC) ("Singular Genomics" or the "Company"), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics
- 1y agoOMICSingular Genomics Reports Recent Updates and Third Quarter 2024 Financial ResultsGlobeNewswireSAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang CapitalGlobeNewswireSAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics Receives Non-Binding Acquisition Proposal from DeerfieldGlobeNewswireSAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics Systems, Inc. (OMIC) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoOMICSingular Genomics Reports Recent Highlights and Second Quarter 2024 Financial ResultsGlobeNewswireSAN DIEGO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024GlobeNewswireSAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswireSAN DIEGO, July 15, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics Announces 1-for-30 Reverse Stock SplitGlobeNewswireSAN DIEGO, June 21, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics to Present at the Goldman Sachs Global Healthcare ConferenceGlobeNewswireSAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics Systems, Inc. (OMIC) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoOMICSingular Genomics Reports Recent Highlights and First Quarter 2024 Financial ResultsGlobeNewswireSAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024GlobeNewswireSAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics Systems, Inc. (OMIC) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoOMICSingular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewswireSAN DIEGO, March 18, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024GlobeNewswireSAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing PlatformGlobeNewswireSAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic AnalysisGlobeNewswireSAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and
- 2y agoOMICSingular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 RevenueGlobeNewswireSAN DIEGO, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 2y agoOMICSingular Genomics Reports Recent Highlights and Third Quarter 2023 Financial ResultsGlobeNewswireSAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoOMICSingular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023GlobeNewswireSAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoOMICSingular Genomics to Present at the Gilmartin Group Emerging Growth Company ShowcaseGlobeNewswireSAN DIEGO, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and
- 3y agoOMICSingular Genomics Reports Recent Highlights and Second Quarter 2023 Financial ResultsGlobeNewswireSAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoLHOMICSingular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of DirectorsGlobeNewswireSAN DIEGO, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoOMICSingular Genomics Announces Participation in the UBS MedTech, Tools and Genomics SummitGlobeNewswireSAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoOMICSingular Genomics to Report Second Quarter 2023 Financial Results on August 9, 2023GlobeNewswireSAN DIEGO, July 26, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoOMICSingular Genomics to Present at the Goldman Sachs Global Healthcare ConferenceGlobeNewswireSAN DIEGO, June 01, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoOMICSingular Genomics Reports Recent Highlights and First Quarter 2023 Financial ResultsGlobeNewswireSAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoOMICSingular Genomics to Report First Quarter 2023 Financial Results on May 9, 2023GlobeNewswireSAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and
- 3y agoOMICSingular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewswireSAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and
- 3y agoOMICSingular Genomics to Present at Cowen's 43rd Annual Health Care ConferenceGlobeNewswireSAN DIEGO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoOMICSingular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023GlobeNewswireSAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoOMICSingular Genomics Launches Max Read™ Kits for Single Cell Sequencing on the G4 at AGBTGlobeNewswire- New next-generation sequencing kit maximizes throughput and decreases the cost for single cell experiments - - Company announces increased quality and throughput specifications of the G4 Sequencing Platform - SAN
- 3y agoOMICSingular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBTGlobeNewswireSAN DIEGO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoOMICSingular Genomics Joins the 10x Genomics Compatible Partner ProgramGlobeNewswire– Demonstrates compatibility of the G4 Sequencing Platform with 10x Genomics Single Cell Applications – SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging
- 3y agoOMICSingular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 RevenueGlobeNewswireSAN DIEGO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 3y agoOMICSingular Genomics to Present at the 41st Annual J.P. Morgan Healthcare ConferenceGlobeNewswireSAN DIEGO, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 4y agoOMICSingular Genomics Reports Recent Highlights and Third Quarter 2022 Financial ResultsGlobeNewswireSAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 4y agoOMICSingular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022GlobeNewswireSAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians,
- 4y agoOMICSingular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company ShowcaseGlobeNewswireSAN DIEGO, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced its presentation
- 4y agoOMICSingular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company ShowcaseGlobeNewswireSAN DIEGO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present
- 4y agoOMICSingular Genomics Reports Recent Highlights and Second Quarter 2022 Financial ResultsGlobeNewswireSAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporat
- 4y agoOMICSingular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call TranscriptEarnings Call TranscriptsOMIC earnings call for the period ending June 30, 2022.
- 4y agoOMICSingular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations SummitGlobeNewswireSAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced its presentation
- 4y agoOMICSingular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial OfficerGlobeNewswireSAN DIEGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the appointment o
- 4y agoOMICSingular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations SummitGlobeNewswireSAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present